Diet and the Brain
A diet rich in fruits, vegetables, and whole grains, and low in fats and added sugars, can reduce the risk of heart disease, diabetes, and obesity. Can certain dietary patterns or components also help preserve cognitive function and reduce the risk of Alzheimer's disease?
Epidemiological studies have suggested that consuming foods rich in antioxidants—such as brightly colored fruits and dark green, leafy vegetables—may be one way to preserve cognition. Antioxidants, molecules capable of slowing the oxidation of other molecules, are thought to reduce cell damage throughout the body by counteracting free radicals, highly reactive molecules that are by-products of energy production in all cells. With age, either more free radicals are produced, or they are not cleared away as efficiently. They can accumulate in neurons in the brain, causing loss of function. Dr. Cotman describes this oxidative damage as "something like molecular rust." Free radicals occur throughout the body, but the brain's high metabolic rate and long-lived neurons make it particularly vulnerable. The destructive nature of free radicals in the aging brain is yet another focus of AD research.
A team at Harvard Medical School explored the possible benefits of foods high in antioxidants by analyzing epidemiological data from more than thirteen thousand participants aged seventy and older in the Nurses' Health Study. They found that the women who reported eating the greatest amounts of green leafy vegetables (spinach, kale, and romaine lettuce) and cruciferous vegetables (broccoli, cabbage, brussel sprouts, and cauliflower) experienced a slower rate of cognitive decline than women who said they ate the smallest amounts of these vegetables. The apparent benefits of antioxidants remained high even when the scientists accounted for other factors that might have influenced the results, such as the use of vitamins, physical activity, smoking, alcohol consumption, and educational level. Eating fruit did not appear to be associated with improved cognitive ability. The researchers speculated that the high levels of antioxidants and folate (a nutrient that also appears to be important for proper neural activity and cognitive function) in the green leafy and cruciferous vegetables were responsible.
Other epidemiological studies have looked at the whole diet rather than particular components. Studies of adults in Manhattan, for example, link the "Mediterranean diet"—which includes lots of fruits, vegetables, and bread; low to moderate amounts of dairy, fish, poultry, and red wine; small amounts of red meat; and frequent use of olive oil—with a reduced risk of AD and longer survival of people who already had the disease.
Researchers have turned to animal studies to explore the link between diet and AD more directly. In one study conducted on transgenic mice, scientists have found that curcumin, an ingredient in curry that has strong antioxidant and anti-inflammatory properties, prevented the aggregation of beta-amyloid peptides into oligomers and inhibited the toxic effect of these oligomers. Other teams have found that a diet high in DHA, an omega-3 fatty acid found in fish, also reduced beta-amyloid and plaque levels in the brains of transgenic mice. These results are now being tested in a number of clinical trials that are examining the effects of specific dietary components on cognitive decline and AD.
Dr. Cotman and his collaborators have demonstrated that old dogs are for many reasons an even more useful model for this type of research than transgenic mice. Dogs experience cognitive decline as they age and can be tested with cognitive challenges similar to those used in higher order primates and humans. More importantly, their brains naturally accumulate beta-amyloid plaques that are identical to those in people, and the amount of beta-amyloid deposits correlates with the severity of their cognitive decline.
Dr. Cotman collaborated with a research team at the University of Toronto, headed by Dr. William Milgram, to conduct several studies with aged beagles to determine whether an antioxidant-rich diet would improve the dogs' cognitive function, learning ability, and memory. The research team fed the beagles exactly the same diet for three years. ("Try that in a human," Dr. Cotman said. "Nobody is going to eat the same thing for breakfast, lunch, and dinner for three years, but the dogs were fine with it.") The diet was enriched with antioxidants, vitamins E and C, and fruit and vegetable extracts.
The beagles were divided into four groups. A first group was put on the antioxidant supplement diet. The second group had an enriched environment with novel toys and a cage companion, as well as additional opportunities to exercise, but no dietary changes. The third group had both the antioxidant-enriched diet and the enriched environment. The fourth group was a control, provided with a regular diet and a standard environment.
Over the three years, the dogs were given a series of behavioral tests similar to cognitive tests used in research with humans and primates. Even in the first few months of the study, the team saw short-term improvements on some of the learning tests. "We were shocked," Dr. Cotman told us.
"When we began the study, the beagles were between eight and eleven years of age—late-middle age for a dog. We picked this age because we wanted to see if we could make a difference as they aged. At year one, we gave them a hard learning task. None of the animals could perform it. At year two, we started to see an improvement in the animals that were in the combined enrichment and diet group. By year three, the animals on the combined enrichment and antioxidant diet were able to perform the task, but the others still couldn't do it." (The animals that received the enriched diet alone and the behavior enrichment alone also showed improvement—just not as much as those in the group that received both.)
Dr. Cotman took this to mean that this group had gained function. "They were now performing almost as well as a group of younger animals." The study received a good deal of press coverage, and one publication described the results as: "You can teach an old dog new tricks." Dr. Cotman agreed that "it's what we did. We taught an old dog new tricks."
"I'd like to believe that you could teach an old individual new tricks, as well. I'm trying to practice this myself. For instance, I'm learning how to play tennis, which I didn't really know how to do a couple of years ago. So I'm learning a new trick, so to speak—and I'm doing okay at it."
Previous: Exercise and the Brain
Excerpted from THE ALZHEIMER'S PROJECT: MOMENTUM IN SCIENCE, published by Public Affairs, www.publicaffairsbooks.com.
In This Section
- Building Cognitive Reserve
- Brain Efficiency
- The Role of Education
- Brain Building
- Personality Factors and Social Networks
- Assessing the Potential Benefits of Exercise and Diet
- Exercise and the Brain
- Diet and the Brain
- Developing New Drug Treatments
- Drugs in Development
- Practical Challenges
Momentum in Science: The Supplementary Series
- Understanding and Attacking Alzheimer's 12 min
- How Far We Have Come in Alzheimer's Research 15 min
- Identifying Mild Cognitive Impairment 20 min
- The Role of Genetics in Alzheimer's 12 min
- Advances in Brain Imaging 11 min
- Looking Into the Future of Alzheimer's 6 min
- The Connection Between Insulin and Alzheimer's 21 min
- Inflammation, the Immune System, and Alzheimer's 29 min
- The Benefit of Diet and Exercise in Alzheimer's 16 min
- Cognitive Reserve: What the Religious Orders Study is Revealing about Alzheimer's 20 min
- Searching for an Alzheimer's Cure: The Story of Flurizan 30 min
- The Pulse of Drug Development 15 min
- The DeMoe Family: Early-Onset Alzheimer's Genetics 25 min
- The Nanney/Felts Family: Late-Onset Alzheimer's Genetics 20 min
- The Quest for Biomarkers 17 min
Video: Inside the Brain: Unraveling the Mystery of Alzheimer's Disease
This 4-minute captioned video shows the progression of Alzheimer's disease in the brain.
Inside the Brain: An Interactive Tour
The Brain Tour explains how the brain works and how Alzheimer's affects it.
Alzheimer's Disease: Unraveling the Mystery
This book explains what AD is, describes the main areas in which researchers are working, and highlights new approaches for helping families and friends care for people with AD.
- About The Scientists
Connect with Alzheimer's Research
Find out how you can participate in clinical trials or studies, find a research center, or get up-to-date information at 1-800-438-4380.
The Alzheimer's Association 24/7 Helpline provides reliable information and support to all those who need assistance. Call us toll-free anytime day or night at 1-800-272-3900.
Create A Tribute
Honor someone you care about and share your stories by contributing to The Tribute Wall on Facebook.
The Alzheimer's Association message boards and chat rooms are your online communication forum. Share your thoughts and experiences, query your colleagues, and make new friends.
- Rapid advances in our knowledge about AD have led to the development of promising new drugs and treatment strategies. However, before these new strategies can be used in clinical practice, they must be shown to work in people. Advances in prevention and treatment are only possible thanks to volunteers who participate in clinical trials.
- Among those touched by Alzheimer's (excluding self), nearly one-third provide support as a friend or relative, another 3% provide support as a healthcare professional, and the remaining two-thirds provide no support to the person suffering from Alzheimer's. When support is provided, it most often entails emotional support, followed by care-giving support. While small in comparison, more than one person in ten is providing financial support. Read more.